Zeo ScientifiX (ZEOX) Operating Expenses (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Operating Expenses of $2.6 million for Q2 2026, up 11.55% year-over-year from $2.3 million in Q2 2025, and up 25.99% quarter-over-quarter from $2.1 million in Q1 2026.
Zeo ScientifiX (ZEOX) Operating Expenses (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Operating Expenses history runs 15 years deep, the most recent figure standing at $2.6 million for Q2 2026.
- In Q2 2026, Operating Expenses rose 11.55% year-over-year to $2.6 million; the TTM figure through Apr 2026 stood at $9.9 million (up 9.55% YoY), while the FY2025 annual figure was $9.8 million, up 5.35% from the prior year.
- Operating Expenses for Q2 2026 stood at $2.6 million, up from $2.1 million in the prior quarter.
- The five-year high for Operating Expenses was $4.4 million in Q4 2022, with the low at $2.1 million in Q1 2026.
- The 5-year median for Operating Expenses is $2.5 million (2023), against an average of $2.7 million.
- Peak annual rise in Operating Expenses reached 73.43% in 2022, while the deepest fall reached 66.99% in 2022.
- Zeo ScientifiX's Operating Expenses stood at $4.4 million in 2022, then plunged by 42.11% to $2.5 million in 2023, then fell by 3.05% to $2.4 million in 2024, then retreated by 15.47% to $2.1 million in 2025, then gained by 25.75% to $2.6 million in 2026.
- Business Quant data shows ZEOX's Operating Expenses at $2.6 million in Q2 2026, $2.1 million in Q1 2026, and $2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 541.02 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.60 Mn |
| Jan 31, 2026 | 2.06 Mn |
| Oct 31, 2025 | 2.07 Mn |
| Jul 31, 2025 | 3.15 Mn |
| Apr 30, 2025 | 2.33 Mn |
| Jan 31, 2025 | 2.16 Mn |
| Oct 31, 2024 | 2.44 Mn |
| Jul 31, 2024 | 2.08 Mn |
| Apr 30, 2024 | 2.41 Mn |
| Jan 31, 2024 | 2.16 Mn |
| Oct 31, 2023 | 2.52 Mn |
| Jul 31, 2023 | 2.51 Mn |
| Apr 30, 2023 | 2.65 Mn |
| Jan 31, 2023 | 3.14 Mn |
| Oct 31, 2022 | 4.36 Mn |
| Jul 31, 2022 | 4.27 Mn |
| Apr 30, 2022 | 2.87 Mn |
| Jan 31, 2022 | 3.09 Mn |
| Oct 31, 2021 | 2.51 Mn |
| Jul 31, 2021 | 2.62 Mn |